REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-20. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Derived from published structure. |
| Molecular weight | 437.94 g/mol | Calculated value. |
| Appearance | White to off-white solid | Typical for purified research samples. |
| Solubility | DMSO, ethanol; low in water | Class: poorly water-soluble. |
| Typical storage | -20 °C, desiccated, protected from light | Limits degradation. |
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Micelles consist of a hydrophobic inner core surrounded by a hydrophilic outer shell that is exposed to a solvent, and their structures can be spheres, disks or wormlike assemblies. Micelles form spontaneously when the concentration is above a critical micelle concentration and temperature. Amphiphiles with an intermediate level of hydrophobicity prefer to assemble into bilayer vesicles. Vesicles are spherical, hollow, lamellar structures that surround an aqueous core. The hydrophobic moiety faces inwards and forms the inner section of the bilayer, and the hydrophilic moiety is exposed to the aqueous environment on the inner and outer surface. Micelle structures have a hydrophobic interior and hydrophilic exterior. There is normally a distinct relationship between the amphiphilic character of a peptide and its function in that the amphiphilic character determines the self-assembly properties, and in turn this is what gives the peptide its functionality. The level of amphiphilicity can vary significantly in peptides and proteins; as such they can display regions that are either hydrophobic or hydrophilic in nature. An example of this is the cylindrical structure of an α-helix, as it could contain a section of hydrophobic residues along one face of the cylinder and a hydrophilic section of residues on the opposite face of the cylinder. For β-sheet structures, the peptide chain can be composed of alternating hydrophilic and hydrophobic residues, so that the side chains of the residues are displayed on opposite faces of the sheet.
dihydrodipicolinate + H2O Once dihydrodipicolinate is synthesized, it can continue down the metabolic pathway leading to the synthesis of lysine. Other than the lysine biosynthetic pathway, L-aspartate-4-semialdehyde can also undergo a reversible reaction catalyzed by the enzyme homoserine dehydrogenase. This reaction, which turns L-aspartate-4-semialdehyde into homoserine is shown below:
== SEM-EDX results == A positive result using SEM-EDX spectroscopy will generate x-ray spectra characteristic of GSR, likely containing combinations of metals such as Pb-Sb-Ba or Sb-Ba. Spectra may also indicate the presence of Ca, S and Si but is not always indicative of GSR. GSR may be present when an individual discharged a firearm or was close by when a discharge occurred. GSR has been observed to undergo both secondary and tertiary transfers, meaning the presence of GSR may be attributed to the persistence of the residue and the unpredictability of human interaction. A negative result on someone could mean they were near it but not close enough for gunshot residue to land on them, or it can mean that the gunshot residue deposited on them wore off. Gunshot residue can also be removed from surfaces by washing, wiping, or brushing it off, so a negative result cannot fully rule out a gun was not fired by the tested object or area. Expelled gunshot residue does not travel very far from the muzzle because the particles lack momentum. Depending on the type of fire arm and ammunition used, it will typically travel no farther than 3–5 feet (0.9–1.5 meters) from the muzzle of the gun.
Sources: en.wikipedia.org
=== Clarifications on terminology === Macrophages have been classified as M1 or M2 depending on the adaptive immune response that elicited the phenotype: Th1 or Th2 respectively. The phrase 'alternatively activated macrophage' is used to refer to M2 macrophages. Regulatory macrophages do not fit into the M1/M2 classification system, and they display different markers.
Singapore and Sri Lanka. ISCEA's Certified Lean Master (CLM) programme is delivered in Hong Kong and Malaysia through SGS, the global inspection, verification, testing and certification entity. In 2019 Tim Charlton was appointed to the position of President of ISCEA-Pacific (Australia and New Zealand) and also appointed to the ISCEA- APAC Board that included Mr. Ejazur Rahman (Bangladesh) CEO, ISCEA-Asia, Mr. Nikhil Oswal (India), CEO, ISCEA-India, Dr. Premkumar Rajagopal (Malaysia), President, MUST (Malaysia University of Science and Technology), Mr. Sandeep Chatterjee (India), Senior Manager, Deloitte India, Dr. Nyoman Pujawan, Ph.D., (Indonesia), Professor, Institut Teknologi Sepuluh Nopember, and Dr. Harish Pant (India), Chief Business Transformation Officer, NTF (India) Pvt. Ltd. In 2024, ISCEA started a partnership with Singapore-based SCALA - Supply Chain and Logistics Academy. SCALA (Singapore) and PPLC Superport & Industrial Co., LTD. (Cambodia) signed a historic Memorandum of Understanding (MoU) to train up to 300 Cambodian trainees in Singapore. The training included hands-on experiential learning and certification as Certified Supply Chain Analysts from ISCEA. The MoU signing was further marked at the Cambodia-Singapore Business Forum in the presence of Samdech Moha Borvor Thipadei Hun Manet, Prime Minister of the Kingdom of Cambodia.
During the process of creating new queens, the workers construct special queen cells. The larvae in these cells are fed with copious amounts of royal jelly. This type of feeding in part triggers the development of queen morphology, including the fully developed ovaries needed to lay eggs. Note however that some newer research shows it is not solely the presence of royal jelly that develops the queen but rather the absence of certain other nutrients fed to worker bees. Royal jelly is sometimes used in alternative medicine under the category apitherapy. It is often sold as a dietary supplement for humans, but the European Food Safety Authority concluded in 2011 that evidence does not support the claim that consuming royal jelly offers health benefits to humans. In the United States, the Food and Drug Administration has taken legal action against companies that have marketed royal jelly products using unfounded claims of health benefits.
Sources: en.wikipedia.org
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.
No. SR9009 targets the nuclear receptors REV-ERBα and REV-ERBβ, not the androgen receptor. This mechanism differs from selective androgen receptor modulators and from exercise mimetics that act on PPARδ.
Published evidence is mainly preclinical, using cell cultures and animal models. Controlled human trials are not well documented in the public literature. Claims about human performance or health effects therefore remain unsupported by robust clinical data.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.